While most of digital health is still serving up step counts and calorie calculators dressed as breakthroughs, Jahangir Mohammed, Terry Poon, and M.A. Maluk Mohamed have been running a different race entirely. Their Whole Body Digital Twin technology doesn’t just track data, it rewrites the metabolic script with precision medicine at scale. And the results aren’t whispers, they’re statistics that make insurers, employers, and yes, pharmaceutical giants, sit forward.
Seventy-one percent of participants in a Cleveland Clinic study hit A1C below 6.5 without glucose-lowering meds other than metformin. 85% dropped GLP-1s. Nearly half eliminated insulin. 73% walked away from injections. Average weight loss in clinical trials? 27 pounds. That’s not wellness marketing, that’s science dismantling the chronic disease economy in real time.
Investors have noticed. Twin Health just raised $53M in Series E, led by Maj Invest out of Denmark, with ICONIQ and Temasek doubling down. Post-money valuation now sits at $950 million. Stack that on top of prior backing from Sequoia Capital, Corner Ventures, Sofina, Helena, Peak XV Partners, Perceptive Advisors, and LTS Investments, and you’ve got $266,280 million in total funding. Conviction runs deep when this many disciplined firms keep writing checks.
The leadership team makes the numbers make sense. Jahangir Mohammed already built Jasper Technologies into a $1.4B Cisco acquisition. Terry Poon brings MIT engineering horsepower and ten patents. M.A. Maluk Mohamed authored more than 237 research papers before anchoring Twin’s India operations. Lisa Shah, MD adds clinical firepower from Duke, Chicago, and Johns Hopkins. CFO Tom Samuelson and CLO Jennifer Bealer round out a bench designed for Fortune 500 boardrooms and beyond.
The business model is as sharp as the outcomes. Employers and health plans only pay when members get healthier, saving an average of $8,400 per year per high-cost patient. That’s why Walmart, Blackstone, Medline, HCSC, Benjamin Moore, Berkshire Hathaway, and others are already on board. And with retention above 90% and churn under 1%, the demand curve is undeniable.
Now Twin Health is aiming higher: scaling to 1M members, expanding Blue Cross Blue Shield partnerships, pushing sustainable GLP-1 alternatives, and taking operations beyond the U.S. and India. The global digital twin market is forecast to grow from $902 million in 2024 to more than $9 billion by 2034, and metabolic health is ground zero.
This isn’t another health tech pitch. This is a company proving that when you model the body in real time and treat dysfunction at the root, you don’t just predict the future of medicine, you manufacture it.
